Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.182 | Paternal factors and perinatal outcomes in assisted reproductive technologies |
Prof. LI Tin Chiu 李天照 |
| 2019.177 | A comparison of serial serum endometrial and decidual markers 9 - 18 days after embryo transfer in women with different pregnancy outcome |
Prof. LI Tin Chiu 李天照 |
| 2014.650 | The value of 3D/4D ultrasound in predicting and improving outcomes in women with reproductive failure | Prof. LI Tin Chiu |
| 2015.534 | The association between psychological and physical stress and clinical outcomes in couples undergoing treatment for infertility |
Prof. LI Tin Chiu 李天照 |
| 2014.575 | The relationship between peripheral/ uterine natural killer (NK) cells and angiogenesis during the time of embryo implantation | Prof. LI Tin Chiu |
| 2019.407 | A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects | Dr. LI Timothy Chun Man |
| 2018.217 | A clinical decision support tool to predict extended-spectrum-beta-lactamase-producing organism in patients with urinary tract infection: its role in antimicrobial stewardship |
Dr. LI Timothy Chun Man 李俊文 |
| 2018.132 | Optimization of antibiotics treatment duration in bloodstream infections with a serum procalcitonin-based algorithm |
Dr. LI Timothy Chun Man 李俊文 |
| 2021.326 | Effect of a Brief Repetitive Negative Thinking Focused (RNT-f) Intervention on Patients with Common Mental Disorders in Hong Kong |
Ms. LI Suk Man 李淑雯 |
| 2011.445 | Impact of a happiness-enhancing project on the level of happiness & perceived stress among psychiatric personnel | Ms LI SUK MAN |
| 2007.505 | The Molecular Epidemiology and Evolution of Heaptitis C Genotype 6a in Hong Kong | Dr Li Suet-Yee Cheryl |
| 2021.335 | Effectiveness of Home-based Family Caregiver-delivered Aromatherapy Programme for the Management of Behavioural and Psychological Symptoms of Dementia for Older Persons with Dementia |
Ms. LI Siu Yin 李小燕 |
| 2023.154 | Mitochondrial disease related mortality - evaluation of a large international cohort | Dr. LI Siu Hung |
| 2010.554 | A prospective study on reference values for normal motor and sensory nerves assessed by routine nerve conduction study among the Hong Kong Chinese | Dr. LI Siu Hung |
| 2025.117 | The effects of transcranial direct current stimulation and cognitive behavioural programme on post-stroke fatigue | Dr LI SIU HUNG |
| 2023.370 | A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack |
Dr. LI Siu Hung SIU HUNG LI |
| 2017.613 | A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke and Death in Patients with Acute Ischaemic Stroke or Transient Ischaemic Attack [THALES - Acute STroke or Transient IscHaemic Attack Treated with TicAgreLor and ASA for PrEvention of Stroke and Death] |
Dr. LI Siu Hung 李少雄 |
| 2018.311 | Retrospective study of mitochondrial disorder in Hong Kong |
Dr. LI Siu Hung 李少雄 |
| 2015.423 | Autoimmune encephalitis in Hong Kong : A retrospective study of clinical characteristics and outcomes |
Dr. LI Siu Hung 李少雄 |
| 2017.348 | Prevalence of neuromyelitis optica in Hong Kong |
Dr. LI Siu Hung 李少雄 |
| 2025.366 | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of VRN110755 in Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) | Dr LI Siu Ching Molly |
| 2024.722 | Artificial intelligence as first-reader for lung cancer screening in high-risk non-smokers: a diagnostic validation study | Doctor Li Siu Ching |
| 2025.339 | Lung Cancer Biomarker: Methylation Risk Score for Early Detection and Minimal Residual Disease Monitoring | Dr. LI Siu Ching |
| 2022.236 | Evaluation of Immune Tumour Microenvironment of EGFR mutation positive NSCLC after Osimertinib treatment |
Dr. LI Siu Ching 李兆澄 |
| 2022.253 | Establishment of New Territories East Cluster Lung Cancer Database |
Dr. LI Siu Ching 李兆澄 |
| 2022.364 | Investigating the genomic landscape and evolution and its impact on clinical outcome in ALK-positive non-small cell lung cancer |
Dr. LI Siu Ching 李兆澄 |
| 2023.099 | Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer: an open-label, multicenter, single arm phase 2 study |
Dr. LI Siu Ching 李兆澄 |
| 2023.101 | Effect of IL24-expressing mesenchymal stem cells on immune system in lung cancer patients and health donors |
Dr. LI Siu Ching 李兆澄 |
| 2023.590 | A randomized controlled trial of an acceptance and commitment therapy-based parenting program for improving parenting stress and other health outcomes of parents and children with autism spectrum disorder |
Miss. LI Sini 李斯妮 |
| 2016.546 | Eye-hand Coordination, Visual Attention, and Physical Activity in Children with Cerebral Palsy |
Miss LI Ru 李如 |
| 2009.468 | Effect of a modified Tai Chi exercise on quality of life, anxiety and deprssion among stroke patients: a quasi-experimental study | Mr Li Pui On |
| 2016.419 | Low back pain self-management: evaluation of an intensive in-patient low back pain education program for female elderly with low back pain: A cohort study |
Miss LI Pui Man 李佩雯 |
| 2024.084 | Validation of the Chinese Fall Efficacy Scale (FES) | Ms. LI Pui Man |
| 2017.410 | The experience of patients and family caregivers in managing pneumoconiosis in the family context: An exploratory qualitative study | Prof. LI Polly Wai Chi |
| 2017.595 | Promoting brain health among people with suboptimal cognitive functioning in Hong Kong: A Brain Vitality Enhancement (BRAVE) program | Prof. LI Polly Wai Chi |
| 2019.086 | The effects of an empowerment-based cognitive behavioural therapy for insomnia on sleep, cognitive function and health-related quality of life in persons with mild cognitive impairment: A waitlist randomized controlled trial | Prof. LI Polly Wai Chi |
| 2018.430 | Psychometric evaluation of the Chinese version of the Atrial Fibrillation Effect on QualiTy-of-Life questionnaire and the Atrial Fibrillation Knowledge Scale | Prof. LI Polly Wai Chi |
| 2010.015 | Management of Diabetes Patients in a Primary CARE Setting - Health-Related Quality of Life and Anxiety Scores | Professor Li Philip Kam-tao |
| 2016.672 | Developing Gistful Thinking and Cognitive Flexibility among High-Functioning Adolescents with Autism Spectrum Disorder |
Mr. LI Philip Hung Kong 李鴻鋼 |
| 2011.051 | Evaluation of Quality of Care – Haemodialysis Public-Private-Partnership, HA | Prof. LI Philip |
| 2019.514 | EBBI, the key to excellent functional outcome in Chinese paediatric patients with lower extremity bone sarcoma | Dr . LI Moses Man Lung |
| 2023.149 | A Phase II, Open-label, Single-arm, Multi-centre Study to Evaluate the Safety and Efficacy of Osimertinib with Amivantamab as First-line Treatment in Participants with Epidermal Growth Factor Receptor Mutation-Positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer (OSTARA) |
Dr. LI Molly Siu Ching 李兆澄 醫生 |
| 2022.392 | A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination with Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non–Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations | Dr. LI Molly Siu Ching |
| 2022.571 | A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-02: Patients With Disease Progression After Receiving Systemic Treatment for Non-Small-Cell Lung Cancer (NSCLC) |
Dr. LI Molly Siu Ching 李兆澄醫生 |
| 2024.171 | A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects with Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305) | Dr. LI Molly Siu Ching |
| 2024.064 | A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) | Dr. LI Molly Siu Ching |
| 2023.642 | LC-SHIELD (Lung Cancer Screening in HIgh risk nonsmokErs by artificial inteLligence Device) | Dr. LI Molly Siu Ching |
| 2025.459 | A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARASIB AND PEMBROLIZUMAB VERSUS PEMBROLIZUMAB AND PEMETREXED AND CARBOPLATIN OR CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED, KRAS G12C-MUTATED, ADVANCED OR METASTATIC NON-SQUAMOUS NON−SMALL CELL LUNG CANCER | Dr. LI Molly Siu Ching |
| 2024.174 | A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-01: Patients With No Prior Systemic Treatment for Metastatic Non–Small-Cell Lung Cancer (mNSCLC) | Dr. LI Molly Siu Ching |
| 2024.230 | A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARASIB VERSUS SOTORASIB OR ADAGRASIB IN PATIENTS WITH PREVIOUSLY TREATED KRAS G12C-POSITIVE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER | Dr. LI Molly Siu Ching |
Page 115 of 269.